Related Experiment Videos
Morpho-functional study of peritoneum in peritoneal dialysis patients
Silvio Volmer Bertoli1, Laura Buzzi, Daniele Ciurlino
1Nephrology and Dialysis Unit, Policlinico MultiMedica, Sesto San Giovanni, Milan, Italy. silvio.bertoli@multimedica.it
Journal of Nephrology
|July 2, 2003
Summary
Peritoneal dialysis (PD) can impair the peritoneal membrane (PM). Longer PD treatment duration and higher glucose loads are linked to mesothelial damage and sub-mesothelial sclerosis, affecting PM function.
Area of Science:
- Nephrology
- Histopathology
- Peritoneal Dialysis
Background:
- Peritoneal dialysis (PD) is associated with impaired peritoneal membrane (PM) structure and function.
- Understanding the relationship between dialysis parameters and peritoneal histology is crucial for PD patient management.
Purpose of the Study:
- To investigate the correlation between dialysate parameters and the histological and functional characteristics of the peritoneum in PD patients.
- To identify factors contributing to peritoneal membrane damage during PD.
Main Methods:
- Peritoneal biopsies (PB) were obtained from 31 PD patients during catheter removal.
- Peritoneal membrane transport was assessed using the peritoneal equilibration test (PET).
- Histological and immunohistochemical analyses were performed on PB samples.
Main Results:
- Mesothelial impairment was associated with longer PD treatment duration.
- Increased daily glucose load correlated with sub-mesothelial sclerosis (SS) and subendothelial vascular membrane (SVM) alterations.
- High transporters exposed to greater glucose loads showed more frequent SS, linked to vascular injuries but not inflammation.
Conclusions:
- Sub-mesothelial sclerosis (SS) is variable and not a primary cause for PD treatment discontinuation.
- Mesothelial damage is primarily influenced by PD treatment duration.
- Elevated glucose load appears to be a significant damaging factor for the sub-mesothelial layer of the peritoneum.